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Summary
RAP1 is one of the components of shelterin, the capping complex
at chromosome ends or telomeres, although its role in telomere
length maintenance and protection has remained elusive. RAP1
also binds subtelomeric repeats and along chromosome arms,
where it regulates gene expression and has been shown to
function in metabolism control. Telomerase is the enzyme that
elongates telomeres, and its deficiency causes a premature aging
in humans and mice. We describe an unanticipated genetic
interaction between RAP1 and telomerase. While RAP1 deficiency
alone does not impact on mouse survival, mice lacking both RAP1
and telomerase show a progressively decreased survival with
increasing mouse generations compared to telomerase single
mutants. Telomere shortening is more pronounced in Rap1/
Terc/ doubly deficient mice than in the single-mutant Terc/
counterparts, leading to an earlier onset of telomere-induced
DNA damage and degenerative pathologies. Telomerase defi-
ciency abolishes obesity and liver steatohepatitis provoked by
RAP1 deficiency. Using genomewide ChIP sequencing, we find
that progressive telomere shortening owing to telomerase
deficiency leads to re-localization of RAP1 from telomeres and
subtelomeric regions to extratelomeric sites in a genomewide
manner. These findings suggest that although in the presence of
sufficient telomere reserve RAP1 is not a key factor for telomere
maintenance and protection, it plays a crucial role in the context
of telomerase deficiency, thus in agreement with its evolutionary
conservation as a telomere component from yeast to humans.
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Introduction
Mammalian telomeres are composed of tandem repeats of the TTAGGG
sequence bound by a specialized protein complex known as shelterin,
which protects chromosome ends and regulates telomerase activity
(Takai et al., 2003; de Lange, 2005; Martinez & Blasco, 2010, 2011).
Telomere repeats can extend to different lengths in different species,
and this length can also vary depending on the developmental stage and
cell type within a given species (Flores et al., 2008; Marion et al., 2009).
During each cell division cycle, telomeres shorten as a result of the
incomplete replication of linear DNA molecules by conventional DNA
polymerases, the so-called ‘end-replication problem’ (Watson, 1972;
Olovnikov, 1973). Telomerase is a reverse transcriptase (TERT) capable of
compensating telomere attrition through de novo addition of TTAGGG
repeats onto the chromosome ends using an associated RNA component
as template (Terc) (Greider & Blackburn, 1985). Telomerase is expressed
in embryonic stem cells and in most adult stem cell compartments;
however, this is not sufficient to maintain telomere length, and
therefore, telomere shortening takes place with age in most tissues
(Harley et al., 1990; Liu et al., 2007; Flores et al., 2008). This progressive
telomere shortening has been proposed as one of the molecular
hallmarks of aging (Lopez-Otin et al., 2013). Indeed, longevity is
progressively decreased upon successive intercrossing of Terc-deficient
mice, which is concomitant with a decreased mobilization of adult stem
cell populations and premature organ failure. In this regard, Terc-
deficient mice show aging-associated pathologies such as alopecia,
lower body weight, intestinal atrophy, hair graying, infertility, heart
dysfunction, bone marrow aplasia, kidney dysfunction, defective bone
marrow, and proliferative defects of neural stem cells (Lee et al., 1998;
Herrera et al., 1999; Samper et al., 2002; Blasco, 2005; Garcia-Cao
et al., 2006). Telomerase-deficient mice are resistant to cancer, with the
only exception of p53-deficient and TRF2-overexpressing genetic back-
grounds (Artandi et al., 2000; Blanco et al., 2007).
RAP1 is one of the shelterin complexes that protects the telomeres
(for a review, see de Lange, 2005; Martinez & Blasco, 2010, 2011). RAP1
binds to telomeric repeats through its interaction with TRF2 (Li et al.,
2000). Human cell lines lacking RAP1 do not show either a DNA damage
response (DDR) or telomere fusions except in the absence of TRF2 when
RAP1 has a role in inhibition of the NHEJ pathway at telomeres (Sarthy
et al., 2009). The role of human RAP1 in telomere length regulation is
unclear, while some works have reported no telomere length changes in
the absence of RAP1, others have observed telomere lengthening upon
both RAP1 knockdown and RAP1 overexpression (Li et al., 2000;
O’Connor et al., 2004; Sarthy et al., 2009; Kabir et al., 2014). Mouse
cells lacking RAP1 have a moderate increase in fragile telomeres and in
telomeric sister chromatid exchange events but are protected against
telomere fusions (Martinez et al., 2010; Sfeir et al., 2010). Thus, in
contrast to yeast where a crucial role of RAP1 in telomere length
regulation and telomere protection has unequivocally been demon-
strated (Lustig et al., 1990; Sussel & Shore, 1991; Kyrion et al., 1992;
Kanoh & Ishikawa, 2001; Pardo & Marcand, 2005), human and mouse
RAP1 does not seem to have an important function in telomere
protection. Mammalian RAP1 and their unicellular orthologs have been
shown to affect gene expression, and this transcriptional regulatory
function has been proposed to reflect the molecular conservation among
RAP1 proteins (Kabir et al., 2014).
RAP1 also associates to nontelomeric genomic sites where it has been
demonstrated to regulate gene expression (Sarthy et al., 2009; Martinez
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et al., 2010, 2013; Yang et al., 2011; Yeung et al., 2013). Mice lacking
RAP1 are viable but develop obesity, glucose intolerance, and hepatic
steatosis. These signs of metabolic disorders are more pronounce in
females than in males (Martinez et al., 2013; Yeung et al., 2013). Gene
expression profile analyses in liver of adult mice revealed that in the
absence of RAP1, several metabolic pathways are remarkably affected
(Martinez et al., 2013).
If mammalian RAP1 is dispensable for telomere protection, why has
RAP1 been conserved as a mayor telomere-binding protein in mammals?
Given its transcriptional regulatory role, it is possible that RAP1 has been
conserved as a shelterin component to sense changes in telomeric states
and to coordinate the regulation of different signaling pathways involved
in different biological functions such as metabolism and DNA repair. To
address the potential RAP1 role in the response to short telomeres and to
determine whether RAP1 deficiency could rescue the low body weight
presented by late-generation telomerase knockout mice, we generated
the double knockout Rap1/Terc/ mouse model. We found that mice
lacking both RAP1 and telomerase show a progressive decreased survival
with increasing mouse generations as compared to telomerase single
mutants, demonstrating an unanticipated genetic interaction between
RAP1 and telomerase. Telomere shortening was more pronounced in
Rap1/ Terc/ than in Terc/ counterparts, leading to an earlier onset
of DNA damage and its consequent DDR causing an anticipation of
degenerative pathologies in the intestines. In its turn, telomerase
deficiency abolishes RAP1-mediated obesity and liver pathologies asso-
ciated with metabolic syndrome. Cells with shortened telomeres present
less amount of telomere-bound RAP1 but show higher numbers of
RAP1-bound extratelomeric sites genomewide. Our findings demon-
strate that although RAP1 is not a key factor in telomere capping under
normal conditions, under certain cellular stresses such as telomerase
deficiency, RAP1 exerts an important function for telomere length
regulation and protection. These unanticipated findings provide a likely
explanation for the fact that RAP1 is the most evolutionarily conserved
shelterin.
Results
RAP1 abrogation exacerbates loss of organismal survival
associated with short telomeres
To address a putative role of RAP1 in the organismal response to short
telomeres, we generated a Rap1/Terc/ double-mutant mouse by
crossing the Rap1/ with the Terc/ mice (Blasco et al., 1997;
Martinez et al., 2013). The resulting double heterozygous breeding pairs
were used to generate first generation (G1) of single Terc/ and of
double Terc/Rap1/. Large colonies of increasing Terc/ mouse
generations up to the third generation (G3) were generated by
intercrossing G1 and G2 Rap1+/Terc/ pairs. Survival curves were
monitored for the different mouse cohorts under study. As shown in
Fig. 1A,B, increasing generations of G1-G3 Terc/ mice showed a
progressive decrease in both median survival and mean lifespan
compared to telomerase WT controls, in agreement with previous
findings showing a premature loss of mouse survival associated with
short telomeres (Herrera et al., 1999; Garcia-Cao et al., 2006). Rap1
deletion did not impact in mouse survival as shown by similar survival
curves for single Rap1/ mutant mice and Rap1+/+ WT controls
(Martinez et al., 2013; Yeung et al., 2013). Unexpectedly, simultaneous
lack of telomerase and RAP1 in G1-G3 Terc//Rap1/ mice resulted in
decreased survival compared to the RAP1-proficient controls, a differ-
ence that reached statistical significance for the late-generations G2 and
G3 (Fig. 1A,B). This effect was gender-independent as it was observed
both in males and females (Fig. S1A–D, Supporting information). These
results suggest that RAP1 deficiency aggravates the telomerase-
associated loss of organismal survival.
Telomerase deficiency abolishes RAP1-mediated obesity and
liver pathologies
Whole-body Rap1 deletion results in obese mice, being this phenotype
more severe in RAP1-deficient females, while telomerase-deficient mice
have been shown to present lower body weight than WT mice, most
likely owing to intestinal degenerative pathologies (Lee et al., 1998;
Herrera et al., 1999; Martinez et al., 2013; Yeung et al., 2013). To
assess the effects of double RAP1 and telomerase deficiencies on fat
accumulation, we weekly followed body weight from mice of both
genders of the different genotypes under study, Rap1+/+Terc+/+, Rap1/
Terc+/+, G1-G3 Rap1+/+Terc/, and G1-G3 Rap1/Terc/ (Figs 1C and
S1E, Supporting information). RAP1-deficient females showed a pro-
gressive increase in body weight with time from week 8 onwards,
reaching an approximately 25% increase in body weight compared to
WT females at 1 year of age (Fig. 1C). The increased body weight in
Rap1-deficient females was maintained throughout their lifespan
(Fig. S1F, Supporting information). Remarkably, female obesity owing
to Rap1 deficiency was abrogated in G1-G3 Rap1/Terc/ compound
mice and even reversed in G2 Rap1/Terc/ where a significant lower
body weight was observed as compared to G2 Rap1+/+Terc/ females
(Fig. 1C). We did not observed significant differences in body weight
among the different RAP1-proficient and RAP1-deficient male cohorts
(Fig. S1E, Supporting information), in contrast to the moderate increase
in body weight previously observed in a different Rap1-deficient mouse
cohort (Martinez et al., 2013). This difference in the impact of Rap1
deficiency in male body weight might be explained by slight differences
in genetic background associated with generation of the Rap1 Terc
compound mouse colony.
Fig. 1 RAP1 loss decreases survival of telomerase-deficient mice, and telomerase deficiency abolishes RAP1-mediated obesity. (A) Kaplan–Meyer survival curves and (B)
median survival from Kaplan–Meyer plots of Rap1+/+Terc+/+, Rap1/Terc+/+, G1 Rap1+/+Terc/, G1 Rap1/Terc/, G2 Rap1+/+Terc/, G2 Rap1/Terc/, G3 Rap1+/+
Terc/, and G3 Rap1/Terc/ mice from both genders. The percent decrease in median survival in successive generations (G2 and G3) of Rap1/Terc/ compared to
Rap1+/+Terc/ mice is shown (red arrows). Statistical comparisons among genotypes using the log-rank test (A) and Student’s t-test (B) are shown. (C) Body weight curves of
Rap1+/+Terc+/+, Rap1/Terc+/+, G1 Rap1+/+Terc/, G1 Rap1/Terc/, G2 Rap1+/+Terc/, G2 Rap1/Terc/, G3 Rap1+/+Terc/, and G3 Rap1/Terc/ female mice.
The percent weight changes in Rap1/Terc+/+ and in G2 Rap1/Terc/ compared to their Rap1+/+ counterparts at end point are indicated (red arrows). Values and error
bars represent the mean and standard error, respectively. Statistical significances were calculated by the Student’s t-test. (D) Incidence of liver disease at time of death of
mice of the indicated genotype. Statistical significances were calculated by the chi-squared test. (E) Representative light microscopy images of hematoxylin-/eosin-stained
sections of liver diagnosed for hepatitis (left panels) and nonalcoholic steatohepatitis (NASH) (right panels). Upper and lower panels correspond to low- and high-
magnification images, respectively. Scale bars are shown. Examples of inflammatory infiltrates, hepatocellular ballooning degeneration, and macro- and microvesicular
depots are shown in high-magnification inserts. Hepatitis is characterized as lobular inflammation with lymphocytes, macrophages and neutrophiles infiltrates and
hepatocellular ballooning degeneration. NASH is a progressive process that begins with lipid deposition in the liver, showing both macro- and microvesicular fatty changes in
hepatocyte’s cytoplasm followed by hepatocellular ballooning degeneration and lobular multifocal inflammation. (n) Number of mice of each genotype used in the analysis.
**, p<0.01, ***p<0.001, ns: no significant.
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We previously reported that Rap1-deficient mice developed liver
pathologies reminiscent to those associated with metabolic syndrome,
that is, hepatic steatosis and inflammation (Martinez et al., 2013). To
address the impact of telomerase deficiency and short telomeres in these
pathologies, we performed histopathological analysis of the liver in all
the mouse cohorts under study at their time of death. As expected, 50%
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of Rap1/Terc+/+ male and female mice presented liver pathologies that
were classified as either severe multifocal hepatitis or as nonalcoholic
steatohepatitis (NASH) (Fig. 1D,E) (see Appendix S1, Supporting infor-
mation). Importantly, no liver pathologies with the exception of some
few cases of inflammation associated with aged liver were observed in
telomerase-deficient mice regardless of Rap1 genotype (Fig. 1D). These
results indicate that RAP1-mediated liver pathologies are abrogated in
the context of telomerase-deficient mice.
RAP1 abrogation leads to an earlier onset of aging
pathologies associated with short telomeres
To determine the cause of death in the different mouse cohorts, we
performed a full histopathological analysis in all the mice at their end
point. Atrophies of the intestinal epithelia are the most frequent and life-
threatening degenerative lesions associated with short telomeres in
G1-G3 Terc/ mice, which contribute to the early mortality of these
mice (Herrera et al., 1999; Garcia-Cao et al., 2006; Martinez et al.,
2009a). We classified these intestinal pathologies in mild, medium, or
severe according to the pathological findings (see Appendix S1,
Supporting information) (Fig. 2A). Severe intestinal atrophy was absent
in WT and single Rap1-deficient mice at their time of death (Fig. 2B). In
contrast, telomerase-deficient mice showed severe intestinal mucosal
lesions characterized by epithelial and glandular atrophy and inflamma-
tory reactions (Fig 2B). Simultaneous telomerase and RAP1 deficiencies
further increased the frequency of severe lesions, reaching statistical
significance in G2-G3 Rap1/Terc/ compared to the G2-G3 Rap1+/+
Terc/ counterparts (Fig. 2A,B). These observations are in line with the
decreased survival observed in G2-G3 Rap1/Terc/ compared with
their Rap1+/+ counterparts. Histopathological analysis of kidneys, lungs,
spleen, and heart did not reveal any significant differences between
G0-G3 Rap1+/+ and G0-G3 Rap1/ mice (Fig. S2A, Supporting
information).
As the above results were obtained at the time of death, to confirm
that RAP1 deficiency aggravates degenerative pathologies at the GI track
of Terc/ mice, we sacrificed a group of 4–5 healthy young mice per
group before any pathological signs at the age of 40–50 and 22–
28 week old in G0 and G1-G3 groups, respectively. Histopathological
analysis of the GI track revealed that intestinal pathologies observed in
mice showed already generalized degenerative intestinal lesions as well
as inflammation, while none of the G2-Rap1+/+Terc/ mice showed
these lesions in a similar age range. Instead, the G2-Rap1+/+Terc/
animals only showed mild focal lesions. No lesions were observed either
in Rap1+/+Terc+/+, Rap1/Terc+/+ or in G1-Rap1+/+Terc/, while 50%
of the G1-Rap1/Terc/ mice already showed mild atrophy (Fig. 2C,D)
(see Appendix S1, Supporting information). Thus, RAP1 deficiency
accelerates the onset of severe intestinal atrophy in late-generation
telomerase-deficient mice. Histopathological analysis of the liver in these
mice revealed that 75% of the Rap1/ mice already present signs of
hepatosteatosis, while none of the G2-Rap1/Terc/ showed this
pathology (Fig. S2B, Supporting information).
We next analyzed the presence of malignant tumors (i.e. lymphomas
and sarcomas) at the time of death of the different mouse cohorts. RAP1
deficiency did not lead to increased incidence of spontaneous malignant
tumors (Fig. 2E). Telomerase-deficient mice presented a drastically
reduced incidence in malignant tumors at their time of death compared
to Terc+/+ mice (Fig. 3E), in agreement with a potent tumor suppressor
activity of short telomeres (Gonzalez-Suarez et al., 2000). This tumor
protection conferred by telomerase deficiency was not altered in the
absence of RAP1 (Fig. 2E).
RAP1 loss leads to a more pronounce telomere shortening in
proliferative tissues in TERC-deficient mice
The anticipation and increased severity of degenerative GI pathologies in
Terc Rap1 doubly deficient mice suggest a role of RAP1 in telomere
maintenance, which is unveiled in the absence of telomerase. In this
regard, previous analysis of single RAP1-deficient mice suggested that
RAP1 was largely dispensable for telomere maintenance in vivo
(Martinez et al., 2010, 2013).
We set to address the impact of Rap1 deletion in telomere length
maintenance in vivo in various mouse tissues in the context telomerase
deficiency. To this end, we performed telomere quantitative FISH
(Q-FISH) analysis on tissue sections of intestine, liver, and of gelatine-
embedded peripheral white blood cells (PWBC) from mice of the
different genotypes before any pathological signs (same mice as in
Fig. 2C,D). Telomere length was moderately but significantly decreased
in the RAP1-deficient intestines compared with their RAP1-proficient
counterparts, regardless of telomerase status (Fig. 3A). Similarly, we
detected a shorter mean telomere length in peripheral white blood
cells (PWBC) from G1-G2 Rap1/Terc/ compared with their G1-G2
Rap1+/+Terc/ counterparts, while no differences in telomere length
were detected between Rap1/Terc+/+ and Rap1+/+Terc+/+ cohorts
(Fig. 3B). In the case of a nonproliferative tissue, such as the liver, how-
ever, RAP1 deficiency did not affect mean telomere length either
in telomerase WT or in G2 Terc/ livers (Fig. S2C, Supporting
information). These results indicate a role for RAP1 in telomere
maintenance in highly proliferative tissues in the context of telomerase
deficiency.
We next performed Q-FISH analysis on intestine sections at the time
of death in the different mouse cohorts. No significant differences in
nuclear telomere length were detected when comparing Rap1+/+Terc+/+
and to Rap1/Terc+/+ samples (Fig. 3C). Strikingly, the mean nuclear
telomere length of G1-Rap1/Terc/ was dramatically decreased
compared with G1-Rap1+/+Terc/, reaching values similar to those
observed in G3-Rap1+/+Terc/ mice (Fig. 3C). Similarly, the telomere
length of G3-Rap1/Terc/ intestines was significantly reduced
compared to G3-Rap1+/+Terc/. Thus, mean telomere length in both
G1 and G3 Rap1/Terc/ was reduced by 50% compared with G1-G3
Rap1+/+Terc/ controls. Note that acquisition settings used for
microscopy image capture were different in Terc+/+ and Terc/ samples
because the settings used in Terc/ samples resulted in saturated
detention levels in Rap1+/+Terc+/+ and to Rap1/Terc+/+ samples
(Fig. 3C). Altogether, these data indicate that RAP1 suppresses further
telomere shortening associated with tissue homeostasis and aging in the
setting of telomerase-deficient mice, thus unveiling an important role for
RAP1 in in vivo telomere length regulation.
Finally, we analyzed telomere length in mouse embryonic fibroblasts
isolated from the different generation cohorts studied here. To this end,
we first established two independent primary embryonic fibroblasts
(MEFs) from each genotype under study that we later immortalized by
retroviral transduction with SV40 large T (LT) antigen. We carried out Q-
FISH on metaphase spreads of immortalized Rap1+/+Terc+/+, Rap1/
Terc+/+, G1 Rap1+/+Terc/, G1 Rap1/Terc/, G3 Rap1+/+Terc/, and
G3 Rap1/Terc/ MEFs at passage 10 (Fig. 3D). Deletion of Rap1 did
not result in significant differences in mean telomere length between
either Rap1+/+Terc+/+ and Rap1/Terc+/+ or between G1 Rap1+/+Terc/
and G1 Rap1/Terc/, although a modest increase in the percent of
critically short telomeres (below percentile 5) was revealed (Fig. 3D).
However, G3 Rap1/Terc/ MEFs showed a 18% decrease in telomere
fluorescence when compared to their WT controls, which was
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Fig. 2 RAP1 loss aggravates intestinal degenerative pathologies of telomerase-deficient mice. (A) Representative hematoxylin and eosin images of degenerative lesions of
the intestine. Upper and lower panels correspond to low- and high-magnification images. Scale bars are shown. Lesions were classified as mild, medium, and severe lesions
according to the pathological findings. (B) Percentage of mice of the indicated genotypes showing severe intestinal atrophy at the time of death. (C) Percentage of mice of
the indicated genotypes showing mild, medium, or severe intestinal atrophy at time point within their health span period during which animals remain healthy with no
pathological signs. Rap1-WT and Rap1-null telomerase proficient were sacrificed at 25–50 week of age and G1-G2 telomerase-deficient mice at 22–30 week of age. (D)
Representative hematoxylin and eosin images of degenerative and inflammatory lesions of the intestine of healthy young mice. (E) Percentage of mice of the indicated
genotype showing malignant tumors (lymphoma and sarcomas) at their time of death. Statistical comparisons in B, C, and E between genotypes using the chi-squares test
are shown. (n) Number of mice of each genotype used in the analysis. *p<0.05; **, p<0.01, ***p<0.001, ns: no significant.
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Fig. 3 RAP1 loss leads to a decrease in telomere length in proliferative tissues of telomerase-deficient mice. (A, B) Mean telomere fluorescence intensity distribution in small
intestine sections (A) and in peripheral blood (B) of healthy young mice of the indicated genotype as determined by Q-FISH analysis. (C). Mean nuclear telomere fluorescence
intensity in small intestine sections of mice of the indicated genotype at death. (n) Four to five mice per genotype were analyzed. (D) Individual telomere length fluorescence
intensity in metaphase spreads of immortalized MEFs of the indicated genotypes. (n) Two independent MEFs per genotype. Mean values (red lines) and percent telomere
length decrease in Rap1/ as compared to Rap1+/+ in each group (red arrows) are indicated. The percent of critically short telomeres below percentile 5 is shown. (E, F, G, H)
Incidence of signal-free ends (SFE) (E), end-to-end fusions (F), multitelomeric signals (MTS) (G), and telomeric sister chromatid exchange (T-SCE) (H) events in metaphase
spreads of immortalized MEFs of the indicated genotypes. A representative image of each chromosomal aberration is shown below. (n) Two independent MEFs per
genotype. The Student’s t-test was used for statistical analysis in each case. *p<0.05; **, p<0.01, ***p<0.001, ns: no significant.
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accompanied by an 3% increase in the frequency of critically short
telomeres (below percentile 5). In addition, the number of signal-free
ends (SFE) per metaphase was significantly increased by 3-fold in G3
Rap1/Terc/ as compared to their Rap1+/+ counterparts (Fig. 3E).
These results further confirm a role for RAP1 in telomere length
maintenance in the setting of telomerase deficiency.
RAP1 abrogation induces a more severe telomere uncapping
in late-generation Terc-deficient MEFs
Our findings indicate that mice and MEFs lacking RAP1 experience a
faster and enhanced telomere shortening in the absence of telomerase.
However, a putative role for RAP1 in facilitating telomerase action on
chromosome ends is ruled out by our observation that RAP1-mediated
telomere erosion is particularly evident in a telomerase-deficient back-
ground. Thus, the role of RAP1 in telomere length homeostasis must
rather be due to a protective function that is dispensable when
telomeres are long but becomes relevant when telomeres are short.
To address this, we performed cytogenetics analysis on metaphase
spreads of the immortalized MEFs described above (Fig. 3F–G). In
agreement with higher numbers of SFE, we also observed a 2-fold
increase in the number of end-to-end fusion events per metaphase in G3
Rap1/Terc/ compared with G3 Rap1+/+Terc/ MEFs, while no
differences were detected between Rap1/Terc+/+ and Rap1+/+Terc+/+
or between G1 Rap1/Terc/ and G1 Rap1+/+Terc/ MEFs (Fig. 3F).
As previously reported by us (Martinez et al., 2010), Rap1 deletion
induces a moderate increase in the number of multitelomeric signals
(MTS), a telomere aberration that is indicative of telomere fragility
(Martinez et al., 2009b), both in Terc+/+ and in G1-Terc/ MEFs. This
effect was abolished in G3-Terc/ probably due to the presence of high
numbers of SFE (Fig. 3G). In accordance with a RAP1 role in prevention
of homologous recombination at telomeres (Martinez et al., 2010; Sfeir
et al., 2010), we also detected a significant increase in sister telomere
recombination (T-SCE) frequencies in (G0-G1-G3) Rap1-deleted MEFs
compared to Rap1 WT controls as determined by the CO-FISH technique
(Fig. 3H).
RAP1 loss triggers DNA damage and accelerates the DDR
onset in telomerase-deficient mice
Critically short and uncapped telomeres are recognized as DNA double-
strand breaks and, as such, are bound by cH2AX (Hao et al., 2004).
In turn, telomere damage elicits a DDR characterized by activation of
p53 and the cell cycle inhibitor p21 that leads to cessation of
cellular proliferation and cell death, ultimately causing tissue failure
and various age-related pathologies (Flores et al., 2005; Martinez &
Blasco, 2010).
We addressed whether the earlier onset of GI atrophy in G2-Rap1/
Terc/ was associated with an earlier induction of DNA damage and
its associated DDR. We quantify the number of cH2AX-, p53-, and
p21-positive cells in the intestine of mice of the different genotypes
under study. At their time of death, we did not see significant differences
in p53 and p21 levels in the GI tract between different Rap1+/+ and
Rap1/ cohorts (Fig. 4A,B), possibly owing to the fact that these mice
already had overt intestinal pathologies. Thus, we analyzed these
markers at an earlier time in asymptomatic mice of 20–50 weeks of age
(Fig. 4C–E). We did not find significant differences in the numbers of
cH2AX-, p53-, and p21-positive cells between Rap1+/+Terc+/+ and
Rap1/Terc+/+. However, late-generation G2-Rap1/Terc+/+ mice pre-
sented a higher DNA burden and increased p53 and p21 levels
compared to G2-Rap1+/+Terc+/+ (Fig. 4C–E). Furthermore, G2-Rap1/
Terc/ intestines showed higher number of apoptotic cells (positive for
active caspase 3) and reduced proliferation (Ki67-positive cells) com-
pared to G2-Rap1+/+Terc/ (Fig. 4F,G).
Altogether, these results demonstrate that Rap1 deletion in the
context of telomerase deficiency anticipates the induction of p53 and
p21 within tissues, concomitant with increased apoptosis and decreased
proliferation rates in the GI track of late-generation telomerase-deficient
mice, which in turn is accompanied by an anticipated onset of
degenerative pathologies and earlier death.
Increased RAP1 genomic occupancy with decreasing telomere
length
Recruitment of RAP1 to telomeres occurs through interactions with
TRF2, and therefore depended on the number of TRF2 molecules bound
to telomeric DNA (Li et al., 2000; Arat & Griffith, 2012; Bandaria et al.,
2016). Mammalian RAP1 also binds nontelomeric genomic sites where it
regulates gene expression (Sarthy et al., 2009; Martinez et al., 2010,
2013; Yang et al., 2011; Yeung et al., 2013). We hypothesize here that
telomere length could affect the ratio between telomere-bound RAP1
and genomic DNA-bound RAP1 that is available to perform its
transcriptional regulatory function.
To address this, we first studied whether the total cellular RAP1 level
varied with telomere shortening. To do this, we analyzed RAP1 protein
levels by Western blot analysis with whole cell extract from immortalized
Rap1+/+Terc+/+, Rap1/Terc+/+, G1 Rap1+/+Terc/, G1 Rap1/Terc/,
G3 Rap1+/+Terc/, and G3 Rap1/Terc/ MEFs. We found that
progressively shorter telomeres did not affect total RAP1 protein level
(Fig. S3A, Supporting information). We then determined the RAP1
protein levels present at telomere foci by performing double immunoflu-
orescence (IF) with RAP1 and TRF1 antibodies. We used Rap1/Terc+/+
cells as negative control for RAP1 IF (Fig. 5A–C). We found a significant
and progressive decrease in both TRF1 and RAP1 at telomere foci with
decreasing telomere length in G1-G3 telomerase-deficient cells (Fig. 5A,
B). These results suggest that telomere shortening owing to telomerase
deficiency results in decreased RAP1 levels at telomere foci.
To determine whether the RAP1 genomic chromatin-binding peaks
also changed with telomere shortening, we performed a chromatin
immunoprecipitation sequencing (ChIP-seq) assay using the same
immortalized MEFs (passage 10) used for the IF analysis (Fig 5A–C).
The (G0-G1-G3) Rap1-null MEFs were processed in parallel to validate
the specificity of RAP1-associated peaks obtained in Rap1 WT MEFs.
Over 22 million of raw 50-bp reads were collected for each sample
(Table S1, Supporting information). First, we analyzed the representation
of the telomeric repeat TTAGGG in the ChIP-seq raw reads of (G0-G1-
G3) Rap1+/+ vs. (G0-G1-G3) Rap1/ samples before genome alignment.
We found a strong overrepresentation of 50-bp sequences containing
the (TTAGGG)8 repeat in WT Rap1 ChIP-seq as compared to Rap1-null
controls, which showed similar levels to input DNA (Fig. 5D). In addition,
we observed a progressively reduced number of telomeric reads in
successive generations G1-G3 Rap1+/+Terc/ compared with Rap1+/+
Terc+/+ samples, thus confirming that the level of telomere-bound RAP1
is decreased with telomere shortening, in agreement with the RAP1 IF
data (Fig. 5B).
Identification of RAP1-bound genomic binding sites revealed 147,
894 and 2,266 nontelomeric peaks in the comparison between the Rap1
WT and the Rap1-null ChIP-seq G0, G1, and G3 datasets, respectively, at
10E-03 P-value cutoff (GEO accession number, GSE79996). Thus, the
number of RAP1 genomic binding peaks was progressively increased in
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Fig. 4 RAP1 loss enhances DNA damage and accelerates the DDR onset leading to a decrease in proliferation and increase in apoptosis in telomerase-deficient mice. (A, B)
Representative immunohistochemistry images of small intestine sections of mice at time of death of the indicated genotype stained for p53 (A) and p21(B). The mean
number of p53- and p21-positive cells per visual fields and standard error are shown within the images. The comparison between Rap1+/+ and Rap1/ from different Terc
generations (G0-G1-G3) did not reach statistical significance by Student’s t-test. (C–G) Percentage of cH2Ax (C)-, p53 (D)-, p21 (E)-, active caspase-3 (F)-, and KI67 (G)-
positive cells in small intestine sections of healthy young mice of the indicated genotype. Representative immunohistochemistry images are shown to the right en each case.
Statistical significance was calculated by Student’s t-test analysis. (n) Five mice per each genotype. *p<0.05; **, p<0.01, ***p<0.001, ns: no significant.
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cells with progressively shorter telomeres, 6- and 15-fold in G1 and G3
Terc/ higher than in Terc+/+ WT MEFs, respectively (Fig. 5E). In
addition, approximately 40% of the G0 peaks were also found in G1 and
G3, and 75% of the peaks identified in G1 were also detected in G3
(Fig. 5F). A total of 1,604 new RAP1 genomic biding sites were observed
in G3 (Fig. 5F). Altogether, these results demonstrate that telomere
length affects the ratio between telomere-bound RAP1 and genomic
DNA-bound RAP1, leading to decreased RAP1 at telomeres and
increased RAP1 occupancy at the chromosome arms.
We also confirmed our previous findings (Martinez et al., 2010) that
the RAP1 peak density distribution in telomerase-proficient MEFs was
progressively decreasing along the chromosome arms toward the
centromere, presenting the highest density at the subtelomeric region
(Fig. S3B, Supporting information). Interestingly, this trend was inverted
in G1 and G3 telomerase-deficient MEFs that present a more evenly
distributed peak density along the chromosome arms (Fig. S3B, Sup-
porting information). These findings indicate that telomere shortening
not only results in lower RAP1 binding at telomeres but also at
subtelomeric sites.
Effects of shortened telomeres on RAP1-mediated
transcription
To address whether the increased genomic RAP1 occupancy observed in
G1-G3 Terc/ cells resulted in transcriptional changes, we carried out
gene expression analysis by RNA sequencing (RNAseq) analysis from the
same immortalized MEFs used for ChIP-seq above. The results have been
deposited in GEO (GEO accession number, GSE79996). Then, we
performed GSEA analysis in G0-G3 Rap1/ MEFs (Tables S2 and S3,
Supporting information, Fig. 5G). GSEA revealed significant downregu-
lation of pathways involved in lipid metabolism in G0-G3 Rap1/ cells,
being the number of downregulated pathways higher in G3 Rap1/
than in G0 Rap1/. Thus, in G3 Rap1/ MEFs, pathways related to
hormone biosynthesis, adhesion, and fibroblast growth factor receptor
were downregulated as compared to RAP1-proficient counterparts.
These results are in agreement with the proposed role of RAP1 in the
transcriptional activation of genes involved in fatty acid metabolism
(Martinez et al., 2010) and with the increased numbers of RAP1-
genomic binding sites in G3 Rap1+/+ as compared to Rap1+/+ (Fig. 5E–G).
Interestingly, GSEA analysis did not reveal any upregulated pathways in
G3 Rap1/ cells, while several pathways related to cell proliferation,
extension of telomere, DNA repair, and carbohydrate–nucleid acid—
amino acid metabolism were significantly upregulated in G0 Rap1/
(Table S3, Supporting information). This observation likely reflects that
Rap1 deletion induces a basal state of telomere uncapping that is being
repaired by different DNA damage repair pathways, that is, homologous
recombination, ATM signaling, and GG-NER. The fact that no differences
in the activation of these pathways were detected between G3 Rap1+/+
and G3 Rap1/ may indicate that in the context of critically short
telomeres (G3), both Rap1+/+ and Rap1/ MEFs present dysfunctional
telomeres and therefore similarly activate these DNA damage repair-
related pathways. Interestingly, 0.44% of the genes whose expression
was altered > 1.5 fold in G0 Rap1/ presented a RAP1-genomic binding
peak while this figure was increased to 2.3% in G3 Rap1/, consistent
with a higher number of RAP1-binding peaks G3 Rap1+/+ than in G0
Rap1+/+ MEFs (Fig. 5F).
To explore the biological pathways affected by Rap1 deletion, we
performed functional analysis with the significantly deregulated genes
(FDR < 0.05) between G0-G1-G3 Rap1/ cells compared to G0-G1-G3
Rap1+/+ cells. For this, we used the Ingenuity software to find disorders
and disease groups that were significantly affected (FDR < 0.05) in the
three groups (Fig. S4, Supporting information). We found similar
biological functions related with disease in the three groups. We did
not detect deregulation of any particular disorder/disease in cells with
shortened telomeres compared to telomerase-proficient groups that
could underline the reduced survival observed in G3 Rap1/ mice.
These results suggest that reduced survival in the Rap1 Terc doubly
deficient mice is mainly due to RAP1 function in telomere homeostasis.
Discussion
Here, we demonstrate that RAP1 exerts an important role in telomere
maintenance and telomere protection in the context of telomerase
deficiency. In line with this, mice lacking both RAP1 and telomerase
show a progressive decreased survival with increasing mouse genera-
tions compared with telomerase single mutants.
In particular, we observe that telomere erosion due to telomerase
deficiency is enhanced in the absence of RAP1, leading to an earlier onset
of DNA damage and its consequent DDR (Fig. 6). As a consequence, we
observe an accelerated onset and progression of degenerative patholo-
gies (i.e. GI atrophies) in G3 Rap1/Terc/ compared to G3 Rap1+/+
Terc/, thus leading to shorter mouse survival. These findings unveil a
previously unnoticed role for RAP1 in telomere maintenance and tissue
homeostasis. Importantly, we observed the most drastic pathological
effects of RAP1 deficiency in the context of telomerase deficiency in
proliferative tissues such as the intestinal tract, but not in the low-
proliferating tissues such as liver, lung, spleen, heart, or kidneys,
suggesting that RAP1 is particularly important to maintain homeostasis
of the highly proliferative tissues. In fact, RAP1-mediated effects on
telomere shortening are only observed in proliferative tissues such as
intestines and blood indicating a cell-/tissue-specific RAP1 effect. The
mechanisms underlying the accelerated telomere shortening could be
explained by a faster cycling rate and/or increased ROS in Rap1/Terc/
as compared to Rap1+/+Terc/ intestinal cells. These results are in
agreement with recent findings supporting that interaction between
RAP1 and TRF2 is important for telomere function and chromosome-end
protection (Arat and Griffith 2012; Rai et al., 2016). In particular,
interaction between RAP1 and TRF2 significantly increases the binding
affinity of the complex for double (ds) telomeric repeats and for telomeric
30 ends (Arat et al. 2012). In addition, the TRF2/RAP1 complex has higher
ability to remodel telomeric DNA compared to either component alone.
On long telomeres, the TRF2-RAP1 complex can initiate t-loop formation
and prevention of the DDR. Similarly, on short telomeres where the t-loop
cannot be formed, the TRF2/RAP1 complex can still bind to the ds-ss
telomere junction due its high affinity for this structure and suppress the
unnecessary DDR by blocking the end and making it less accessible to
DNA repair machinery and thereby exerting a protective role (Arat et al.
2012). Thus, our results could be in agreement with a model in which
t-loop formation of critically short telomeres after replication is fur-
ther compromised in RAP1-depleted cells, being more susceptible to
telomere degradation by nucleases. Indeed, RAP1 was recently reported
to protect from end-to-end fusions in cells with topologically
compromised telomeric DNA with significantly reduced cellular t-loop
content (Benarroch-Popivker et al., 2016). In agreement with this,
G3 Rap1/ cells present higher incidence of end-to-end fusions (see
Fig. 3F).
RAP1 has also been shown to be essential to protect telomeres from
homology-directed repair as its loss induces telomeric sister chromatin
recombination (Martinez et al., 2010; Sfeir et al., 2010; Rai et al., 2016).
Here, we confirm a moderate increase in telomeric homologous
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recombination (HR) in the absence of RAP1 regardless of the underlying
telomere length, supporting an antirec function of RAP1. Indeed, it has
recently been shown that RAP1 cooperates with the basic domain of
TRF2 (TRF2B) to repress the HR factors PARP1 and SLX4 localization to
telomeres. In the absence of RAP1 and TRF2B, PARP1 and SLX4 promote
telomere resection that results in telomere loss and the generation of
telomere-free chromosome fusions mediated by the HR pathway (Rai
et al., 2016). Thus, it is tempting to speculate that the enhanced
telomere shortening observed in telomerase-deficient cells lacking RAP1
is likely due to increased telomeric HR in the absence of RAP1 (Fig. 6). In
addition, it is also possible that telomerase and RAP1 cooperate to
protect telomeres from degradation during replication of telomeric DNA
tracts through the antirec properties of RAP1.
We also found that RAP1 deficiency did not abolish the tumor
suppressor role of short telomeres and telomerase deficiency (Greenberg
et al., 1999; Gonzalez-Suarez et al., 2000). This observation is partic-
ularly interesting in light of a previous report suggesting a tumor
suppressor role for RAP1 via modulation of the NF-jB-mediated pathway
(Teo et al., 2010). However, our results clearly show that RAP1
deficiency does not affect spontaneous cancer incidence throughout
the lifespan of both telomerase-deficient and telomerase WT mice
(Martinez et al., 2013).
RAP1 protein does not contain a DNA-binding domain (Li et al.,
2000), and therefore, it is proposed to interact with yet unknown
partners to accomplish its transcriptional function (Martinez et al.,
2010). However, human RAP1 can bind in vitro to DNA with a
preference for double-strand–single-strand junction in a sequence-
independent manner (Arat et al. 2012), thus raising the possibility that
direct RAP1 binding to DNA could at least partially account for
nontelomeric function at internal sites on the chromosomes. The
recruitment of RAP1 to the telomeres is accomplished through interac-
tions with the shelterin component TRF2 and is thereby dependent on
the number of TRF2 molecules bound to the telomeric DNA repeats,
which in turn is proportional to the length of telomeres (Li et al., 2000;
Arat & Griffith, 2012; Bandaria et al., 2016). Telomere length is highly
dynamic and does vary among different cell types and along aging
(Harley et al., 1990; Liu et al., 2007; Flores et al., 2008). Thus, it is
therefore conceivable that telomere length would affect the ratio
between telomere-bound RAP1 and genomic DNA-bound RAP1 that is
available to perform its transcriptional regulatory function. Indeed, in
Fig. 6 Proposed model for RAP1 role in telomere function. Cells with normal telomeres show an increased density of RAP1 peaks toward the subtelomeres and telomere,
while this density decreases toward the centromere. As telomeres shorten associated with increasing generations of telomerase-deficient mice, RAP1 occupancy at telomeres
decreases while it increases at extratelomeric genomic sites. Furthermore, RAP1 enrichment at subtelomeric sites is lost when telomeres shortened. Interestingly, while RAP1
loss in cells with normal telomeres is tolerated and does not induce significant telomere shortening or induction of severe DNA damage signaling at telomeres, RAP1
deficiency in a context of telomerase deficiency and critically short telomeres augments telomere homologous recombination, further accelerating telomere shortening and
chromosomal instability. We propose a previously unnoticed role for RAP1 in telomere maintenance in the context of telomerase deficiency and short telomeres, which in
turn results in an anticipated appearance of degenerative capacities and shorter lifespan in mice.
Fig. 5 Progressive increase in extratelomeric RAP1-binding sites in successive generations of telomerase-deficient MEFS. (A, B) Quantification of TRF1 (A) and RAP1 (B) foci
intensity in nuclei of Rap1+/+Terc+/+ and in G1-G3 Rap1+/+Terc/ MEFs by immunofluorescence. Rap1/Terc+/+ cells were used as negative controls. Co-localization of
RAP1 with TRF1 foci was used as control for telomere localization. The Student0s t-test was used for statistical analysis. (n) Two independent MEFs per genotype. (C)
Representative images of TRF1 (green foci) and RAP1 (red foci) doubly IF corresponding to G3 Rap1+/+Terc/ and to Rap1/Terc+/+ samples. (D) Fold change amount of
50-bp raw ChIP-seq reads (before genome alignment) containing perfect TTAGG8 repeats in Rap1
+/+Terc+/+ and (G1-G3) Rap1+/+Terc/ MEFs normalized to input sample.
Rap1/Terc+/+ and (G1-G3) Rap1/Terc/ MEFs were also analyzed as negative controls. The Student’s t-test was used for statistical analysis (E) Number of RAP1 genomic
binding sites identified by ChIP-seq analysis in Rap1+/+Terc+/+ and (G1-G3) Rap1+/+Terc/ MEFs. The fold increases in G1 and G3 samples as compared to Rap1+/+Terc+/+ are
indicated. (F) Venn diagram showing the number of overlapping RAP1 genomic binding peaks among Terc+/+ and G1-G3 Terc/ samples. The total number of genomic
binding sites in each group is indicated. (G) Venn diagram showing the overlapping between the downregulated pathways in Rap1/Terc+/+ and G3 Rap1/Terc/ vs.
their Rap1+/+ counterparts according to GSEA analysis (FDR < 0.25). Note that those pathways found deregulated in G0 were also found downregulated in G3. In G3, cells
lacking RAP1 showed additional downregulated pathways related to hormone biosynthesis, fibroblast growth factor receptor, and adhesion that were not observed in G0.
*p<0.05; ***p<0.001, ns: no significant.
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telomerase-deficient senescent yeast, the levels of Rap1 at telomeres
decrease concomitantly with an increase in Rap1 occupancy at
extratelomeric sites already bound in nonsenescent cells as well as at
other newly identified genomic sites denoted as new Rap1 targets at
senescence (Platt et al., 2013). In addition, Rap1 delocalization con-
tributes to the transcriptional changes observed in senescent cells and it
was suggested that its release from telomere foci is a coordinated
genomic response to telomere shortening (Platt et al., 2013). In
agreement with this notion, here, we find that short telomeres owing
to telomerase deficiency result in decreased RAP1 levels at telomeres as
determined by whole-genome ChIP sequencing, at the same time that
increases RAP1 peaks at extratelomeric genomic sites in cells (Fig. 6). We
also find that the known RAP1 enrichment at subtelomeric sites is lost as
telomeres shorten with increasing mouse generations in the absence of
telomerase, thus suggesting potential effects in subtelomeric gene
silencing (Fig. 6). Accordingly, gene expression profiling in RAP1-
proficient and RAP1-deficient G3-Terc/ MEFs revealed a moderate
higher numbers of deregulated pathways in the absence of RAP1. These
pathways were related to hormone biosynthesis, adhesion, and fibrob-
last growth factor receptor. Our data support that RAP1-mediated
effects on the survival of telomerase-deficient mice are through its
function in telomere homeostasis. However, given that transcriptional
profiling in this work was performed in SV40-LT immortalized MEFs,
affected in many different pathways including p53 and RB, we cannot
rule out that decreased survival in Rap1/Terc/ compound mice could
also partially be attributed to RAP1 role in transcriptional regulation.
Future work aimed to analyze the RAP1-mediated transcriptional effects
in different tissue types of late-generation telomerase-deficient mice is
needed to ultimately unveil RAP1 role in the survival of telomerase-
deficient mice.
The deleterious in vivo effects of single Rap1 deletion are manifested
in the liver and white fat tissues resulting in obesity and hepatic steatosis
(Martinez et al., 2013; Yeung et al., 2013). However, telomerase
deficiency in combination with RAP1 depletion abrogates the obese
phenotype and liver pathologies observed in Rap1 single knockout mice.
One likely explanation to this observation is that the severe intestinal
degenerative pathologies induced by telomerase deficiency impede
proper nutrient absorption at the GI track, thereby inhibiting lipid
accumulation. Alternatively, few critically short telomeres in liver cells as
a consequence of telomerase deficiency could trigger a metabolic
program counteracting the one induced by RAP1 loss.
Our findings demonstrate that although RAP1 is not a key factor in
telomere capping under conditions of a sufficient telomere reserve, in
the settings of telomerase deficiency, RAP1 exerts an important function
in telomere protection and telomere length maintenance, which in turn
is important to delay the appearance of degenerative diseases and for
organismal longevity. These previously uncovered findings explain its
evolutionary conservation as a shelterin component in mammalian cells.
Experimental procedures
Generation of Rap1 Terc double knockout mice
Rap1Terc knockout mice, Rap1/Terc/, were generated by cross-
ing Rap1/ (C57BL6/129SV; 90%: 10%) (Martinez et al., 2013) with
Terc/ mice (C57BL6; 100%) (Blasco et al., 1997). The resulting double
heterozygous breeding pairs were used to generate G1 of single Terc/
and of double Rap1/Terc/. Mouse colonies of successive
generations, G2 and G3, were generated by intercrossing G1 and G2
Rap1+/Terc/ pairs, respectively. All mice were generated and
maintained at Animal Facility of the Spanish National Cancer Research
Centre (CNIO) under specific pathogen-free conditions in accordance
with the recommendation of the Federation of European Laboratory
Animal Science Associations.
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